RPM:NYSERPM International Inc. Analysis

RPM is trading at $104.61, comfortably above its 20‑day ($101.43) and 50‑day ($102.67) simple moving averages, while still below the 200‑day SMA ($109.08), indicating short‑term momentum within a longer‑term downtrend. Technical indicators are mixed: the MACD histogram is positive (0.48) with a bullish signal, the RSI sits at a neutral 55, and the price is approaching the near‑term resistance of $107.99. Fundamentally, the company delivers solid growth—revenue rose 8.9% to $7.71 B, ROE stands at 22.9%, and the dividend yield of 2.06% is supported by a moderate 40% payout ratio. However, the DCF‑derived fair value of $36.27 suggests the stock is significantly overvalued relative to intrinsic estimates, despite a consensus “strong buy” and a median price target of $126, implying roughly 20% upside.
The balance sheet shows a high debt‑to‑equity ratio of 92%, with net debt still sizable after accounting for $0.29 B cash, though operating cash flow ($0.81 B) and free cash flow ($0.38 B) comfortably cover dividend obligations. Volatility is elevated at 28% over the past 30 days and beta is near market (0.97), pointing to moderate market risk. The specialty chemicals sector carries medium regulatory exposure, but the company’s U.S. focus limits geographic and currency risk.
Given the bullish short‑term technical setup, strong cash generation, and attractive dividend, the stock presents a compelling near‑term buying opportunity, yet the large discrepancy between market price and DCF valuation, combined with leverage, advises caution on a longer horizon.